Oct 1, 2019 Oncolytics Biotech(R) Announces Abstract to be Presented at the 34th Annual Meeting of the Society for Immunotherapy of Cancer
Sep 30, 2019 Oncolytics Biotech CEO, Matt Coffey, Honored with Scientific Achievement and Innovation Award by BioAlberta
Sep 25, 2019 Oncolytics Biotech(R) Announces Upcoming Presentation at the 12th Annual International Oncolytics Virus Conference
Sep 5, 2019 Oncolytics Biotech(R) to Present at the H.C. Wainwright 21st Annual Global Investment Conference
Sep 4, 2019 Oncolytics Biotech(R) to Host Corporate Update Call to Discuss Recent Highlights and Expanded Catalysts and Milestones
Aug 16, 2019 Oncolytics Biotech(R) Announces Closing of Its Public Offering of Common Shares and Warrants
Aug 14, 2019 CORRECTION: Oncolytics Biotech(R) Announces Pricing of Its USD $3.7M - CDN $4.9M Public Offering of Common Share and Warrants
